Answers are grounded in this paper and cite their sources.
when subjected to 2.5 and 5% concentrations of chitosan. Our findings demonstrate that chitosan from BSF pupal exuviae could be a promising and novel therapeutic agent for drug development against resistant strains of bacteria.
No takes yet. Share an insight, caveat, or question.
Lagat et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: